Home › Facioscapulohumeral Muscular Dystrophy
Facioscapulohumeral Muscular Dystrophy clinical trials recruiting in the U.S.
7 studies for Facioscapulohumeral Muscular Dystrophy are recruiting participants at sites across the United States.
Cities with the most studies
By state
Recently updated studies
Biomarker Development for Muscular Dystrophies
RecruitingObservational studyHealthy volunteers welcome
Ages 5 and older · All sexes · Updated Oct 29, 2026 · NCT05019625Safety and Preliminary Efficacy of ULSC in Facioscapulohumeral Muscular Dystrophy (FSHD)
RecruitingPhase 1
Ages 15 and older · All sexes · Updated Oct 21, 2026 · NCT07086521Phase 2 Study Evaluating Apitegromab for the Treatment of FSHD
RecruitingPhase 2
Ages 18 to 60 · All sexes · Updated Sep 2, 2026 · NCT07435129Clenbuterol to Target DUX4 in FSHD
RecruitingPhase 1
Ages 18 to 75 · All sexes · Updated Feb 25, 2026 · NCT06721299Motor Outcomes to Validate Evaluations in Pediatric FSHD (MOVE Peds)
RecruitingObservational study
Ages 5 to 17 · All sexes · Updated Feb 25, 2026 · NCT06847282BetterLife FSHD: A Patient-driven Health and Research Platform
RecruitingObservational study
Ages 1 and older · All sexes · Updated Feb 20, 2026 · NCT07409142Myotonic Dystrophy and Facioscapulohumeral Muscular Dystrophy Registry
RecruitingObservational studyHealthy volunteers welcome
All ages · All sexes · Updated Oct 15, 2025 · NCT00082108From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.